The MCF-7 cell line was included because the RARA binding site was originally identified in these cells while the human hepatocellular carcinoma cell line HepG2 was included because the liver plays a prominent role in biological processes relevant to energy metabolism (e.g. carbohydrate and lipid metabolism). Here, RARA is linked to hepatocellular carcinoma.